Foyston Gordon & Payne Inc grew its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,362 shares of the technology company’s stock after buying an additional 993 shares during the period. Foyston Gordon & Payne Inc’s holdings in Amdocs were worth $4,011,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. FMR LLC raised its holdings in Amdocs by 13.6% during the second quarter. FMR LLC now owns 14,342,346 shares of the technology company’s stock worth $924,507,000 after purchasing an additional 1,722,080 shares in the last quarter. Janus Henderson Group PLC raised its holdings in Amdocs by 0.8% during the third quarter. Janus Henderson Group PLC now owns 7,488,518 shares of the technology company’s stock worth $481,661,000 after purchasing an additional 57,372 shares in the last quarter. Boston Partners raised its holdings in Amdocs by 0.4% during the third quarter. Boston Partners now owns 7,139,400 shares of the technology company’s stock worth $459,206,000 after purchasing an additional 27,688 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Amdocs by 5.3% during the third quarter. Wells Fargo & Company MN now owns 4,932,692 shares of the technology company’s stock worth $317,271,000 after purchasing an additional 246,756 shares in the last quarter. Finally, FIL Ltd raised its holdings in Amdocs by 157.9% during the second quarter. FIL Ltd now owns 4,137,393 shares of the technology company’s stock worth $266,696,000 after purchasing an additional 2,532,928 shares in the last quarter. 93.25% of the stock is currently owned by institutional investors.

Amdocs Limited (NASDAQ DOX) opened at $65.15 on Monday. The stock has a market capitalization of $9,469.88, a price-to-earnings ratio of 18.40, a price-to-earnings-growth ratio of 2.24 and a beta of 0.52. Amdocs Limited has a twelve month low of $56.10 and a twelve month high of $67.98.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Wednesday, November 8th. The technology company reported $0.94 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.89 by $0.05. Amdocs had a return on equity of 14.77% and a net margin of 11.30%. The company had revenue of $979.70 million for the quarter, compared to analysts’ expectations of $977.72 million. During the same quarter in the prior year, the company earned $0.89 earnings per share. The firm’s revenue was up 4.2% on a year-over-year basis. sell-side analysts predict that Amdocs Limited will post 3.72 earnings per share for the current fiscal year.

Amdocs declared that its board has authorized a stock repurchase program on Wednesday, November 8th that permits the company to buyback $800.00 million in outstanding shares. This buyback authorization permits the technology company to repurchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Shareholders of record on Friday, December 29th will be given a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a yield of 1.35%. The ex-dividend date is Thursday, December 28th. Amdocs’s payout ratio is 29.73%.

DOX has been the topic of several research reports. Robert W. Baird reaffirmed a “hold” rating and issued a $66.00 price target on shares of Amdocs in a report on Friday, October 20th. Jefferies Group reaffirmed a “hold” rating and issued a $70.00 price target on shares of Amdocs in a report on Thursday, October 12th. BidaskClub cut Amdocs from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 5th. Oppenheimer reaffirmed a “buy” rating and issued a $70.00 price target on shares of Amdocs in a report on Tuesday, September 5th. Finally, Zacks Investment Research cut Amdocs from a “buy” rating to a “hold” rating in a report on Monday, November 13th. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $70.29.

TRADEMARK VIOLATION WARNING: “Amdocs Limited (DOX) Stake Raised by Foyston Gordon & Payne Inc” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/12/11/amdocs-limited-dox-stake-raised-by-foyston-gordon-payne-inc.html.

Amdocs Company Profile

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Stock Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related stocks with our FREE daily email newsletter.